Healthcare Industry News: cardiopulmonary
News Release - March 20, 2007
Vidacare(R) Announces Sales and Marketing Leader for New Hematology/Oncology Business UnitSAN ANTONIO--(HSMN NewsFeed)--VidacareŽ, the leading developer, manufacturer, and marketer of advanced intraosseous access technology for multiple diagnostic, monitoring, and therapeutic applications, today announced the appointment of Becky S. Ariana as senior director of sales and marketing for the company's hematology/oncology business unit.
With more than 30 years of experience in the oncology, pharmaceutical, and medical device industries, Ms. Ariana formerly served as oncology specialist at Millennium Pharmaceuticals. During her tenure there, she successfully launched Velcade, a first-in-class proteasome inhibitor, to the oncology market. Ms. Ariana previously served as sales consultant at Berlex Oncology, where she spearheaded the launch of Campath, a humanized monoclonal antibody, while growing the market share of two other products. Prior to joining Berlex, she developed her own successful marketing consulting business, Medigy, where she served as president for 10 years. Ms. Ariana has also held senior business, analytical and strategic consulting positions at a number of other major healthcare corporations, as well as a position as director of the cardiac and pulmonary departments at Plano General Hospital in Plano, Texas.
"We are very impressed with Becky's business acumen and the strong relationships she's forged within the oncology community," said Philip W. Faris Jr., president and CEO of Vidacare. "She has a wide-range of expertise in introducing innovative new products, and we're extremely pleased to welcome her as the head of the business unit responsible for Vidacare's important new diagnostic and therapeutic products, which hold so much promise for both hematology/oncology providers and their patients."
Ms. Ariana earned an advanced degree in cardiopulmonary therapy from the University of Chicago, and her bachelor's of science degree in zoology and psychology from Iowa State University.
About Vidacare Corporation
VidacareŽ is the leading developer, manufacturer, and marketer of advanced intraosseous (IO) access technology for multiple diagnostic, monitoring, and therapeutic applications. The company's initial product line, the EZ-IOŽ Product System by Vidacare, serves the emergent care industry as the world's only lithium-battery powered drill and patented needle set for gaining immediate vascular access when conventional IV access is difficult or impossible. Vidacare's suite of hematology/oncology products includes a power driver and specially-designed needle sets for bone marrow aspiration and biopsy. The Express Aspiration SystemŽ by Vidacare represents the first in this series of products and will be commercially available in June 2007. Headquartered in San Antonio, Texas, Vidacare was founded in 2001 and owns the exclusive rights to innovative IO technologies developed at the University of Texas Health Science Center-San Antonio. For more information, visit www.vidacare.com.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.